uric acid has been researched along with Hyperhomocysteinemia in 32 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Hyperhomocysteinemia: Condition in which the plasma levels of homocysteine and related metabolites are elevated (
| Excerpt | Relevance | Reference |
|---|---|---|
| "The mechanisms of hyperhomocysteinemia (HHcy) and hyperuricemia (HUA) that promote atherosclerosis were seldom explored and always indefinite." | 8.95 | Role of Hyperhomocysteinemia and Hyperuricemia in Pathogenesis of Atherosclerosis. ( Chen, H; Chen, J; Gu, Y; Liu, N; Yang, K; Zhao, J, 2017) |
| "Hyperhomocysteinemia (HHcy) is known to increase the risk of many diseases." | 8.95 | Determinants of hyperhomocysteinemia in healthy and hypertensive subjects: A population-based study and systematic review. ( Astell-Burt, T; Chen, S; Duan, D; Duan, S; Feng, X; Gu, K; Han, L; Liu, Y; Lu, N; Ma, J; Tang, L; Wang, C; Wang, K; Wen, Q; Xu, G; You, D; Zhang, L; Zhang, T, 2017) |
| "We find evidence that an elevated serum uric acid level is an independent indicator for hyperhomocysteinemia in patients with hypertension." | 8.12 | Serum uric acid concentration is associated with hyperhomocysteinemia in hypertensive Chinese adults. ( Wang, Q; Wang, W; Yang, N, 2022) |
| "Little research has been conducted into the effects of the combined manifestation of hyperuricemia and hyperhomocysteinemia on cardiometabolic risk factors and markers in young subjects." | 8.12 | The Presence of Hyperhomocysteinemia Does Not Aggravate the Cardiometabolic Risk Imposed by Hyperuricemia in Young Individuals: A Retrospective Analysis of a Cross-Sectional Study. ( Gurecká, R; Koborová, I; Podracká, Ľ; Repiská, G; Šebeková, K, 2022) |
| "Aim To determine the relationship of homocysteine (HCY), uric acid (UA) and C-reactive protein (CRP) in serum of patients with acute myocardial infarction (AMI) prior to application of percutaneous coronary intervention (PCI) and their level of correlation in serum of patients with normal and elevated CRP (predictor of worse cardiovascular outcomes)." | 7.88 | A relation of serum homocysteine, uric acid and C-reactive protein level in patients with acute myocardial infarction. ( Brizić, I; Čaušević, A; Jelić Knezović, N; Marković Boras, M; Mikulić, I; Vasilj, M, 2018) |
| " Patients with metabolic syndrome (MS) have higher values of homocysteine." | 7.88 | Homocysteine is the confounding factor of metabolic syndrome-confirmed by siMS score. ( Colak, E; Dimitrijevic-Sreckovic, V; Gacic, J; Janeski, H; Janeski, N; Mrdovic, I; Soldatovic, I; Srećković, B; Sumarac-Dumanovic, M, 2018) |
| "Patients with both hypertension and hyperhomocysteinemia, termed H-type hypertension, have a high risk for cardiocerebrovascular diseases." | 7.85 | Prevalence of Homocysteine-Related Hypertension in Patients With Chronic Kidney Disease. ( Li, Y; Lou, T; Ma, X; Peng, H; Wang, C; Ye, Z; Zhang, J; Zhang, Q, 2017) |
| "To investigate the related factors of serum uric acid in patients with primary hypertension and hyperhomocysteinemia." | 7.83 | Related factors of serum uric acid in patients with primary hypertension and hyperhomocysteinemia. ( Lin, L; Wang, B; Zhao, C, 2016) |
| "The role of hyperhomocysteinemia in coronary artery disease (CAD) patients remains unclear." | 7.83 | Adenosine plasma level correlates with homocysteine and uric acid concentrations in patients with coronary artery disease. ( Bonatti, S; Bruzzese, L; Cuisset, T; Deharo, P; Fenouillet, E; Fromonot, J; Guieu, R; Mottola, G; Quilici, J; Ruf, J, 2016) |
| "Hyperhomocysteinemia (HHcy) is recognized as a risk factor for cardiovascular disease." | 7.83 | High Prevalence of Hyperhomocysteinemia and Its Association with Target Organ Damage in Chinese Patients with Chronic Kidney Disease. ( Li, Y; Lou, T; Ma, X; Peng, H; Wang, C; Ye, Z; Zhang, J; Zhang, Q, 2016) |
| "Hyperhomocysteinemia and hyperuricemia are both considered risk factors for coronary artery disease." | 7.81 | Assessment of a possible link between hyperhomocysteinemia and hyperuricemia. ( Cohen, E; Garty, M; Goldberg, E; Krause, I; Levi, A; Vecht-Lifshitz, SE, 2015) |
| "Hyperhomocysteinemia is one of the important factors of the cardiovascular disease, and gout is well known to be associated with cardiovascular disease." | 7.80 | Elevated serum homocysteine levels were not correlated with serum uric acid levels, but with decreased renal function in gouty patients. ( Choi, ST; Kim, JS; Song, JS, 2014) |
| "Our findings support that hyperhomocysteinemia is a risk factor for AD in an Algerian population and is also associated with vitamin B12 deficiency." | 7.80 | Hyperhomocysteinemia is a risk factor for Alzheimer's disease in an Algerian population. ( Belarbi, S; Bendini, M; Chelouti, H; Djerdjouri, B; El Hadi Cherifi, M; Kacimi, G; Khelil, M; Nazef, K; Tazir, M, 2014) |
| "In the general adult population, elevated serum homocysteine and uric acid were associated with albuminuria independently of each other and of renal function." | 7.77 | Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study. ( Bochud, M; Marques-Vidal, PM; Marti, F; Mooser, V; Paccaud, F; Vollenweider, P; Waeber, G, 2011) |
| "Information on plasma homocysteine concentrations and their associated factors in Brazilian subjects with metabolic syndrome (MS) is nonexistent." | 7.74 | Association of homocysteinemia with high concentrations of serum insulin and uric acid in Brazilian subjects with metabolic syndrome genotyped for C677T polymorphism in the methylenetetrahydrofolate reductase gene. ( Rosa, G; Uehara, SK, 2008) |
| "Plasma total homocysteine, uric acid and allantoin levels of 50 patients with coronary artery diseases and 23 healthy controls were determined by HPLC methods." | 7.73 | Increased plasma homocysteine and allantoin levels in coronary artery disease: possible link between homocysteine and uric acid oxidation. ( Imren, E; Ozkan, Y; Simşek, B; Torun, M; Yardim-Akaydin, S, 2006) |
| "Hyperhomocysteinemia is a risk factor in obstetrical complications such as pre-eclampsia, 'hemolysis, elevated liver enzymes, low platelet' (HELLP)-syndrome and placental insufficiency." | 7.72 | Alteration of homocysteine catabolism in pre-eclampsia, HELLP syndrome and placental insufficiency. ( Geisel, J; Herrmann, W; Hübner, U; Koch, I; Obeid, R; Retzke, U, 2004) |
| "In conclusion, hyperhomocysteinemia is associated with carotid RI, a surrogate marker of cerebral vascular resistance, especially in elderly men." | 5.40 | Hyperhomocysteinemia is one of the risk factors associated with cerebrovascular stiffness in hypertensive patients, especially elderly males. ( Enomoto, D; Higaki, J; Irita, J; Kudo, K; Kukida, M; Miyoshi, K; Nagao, T; Okura, T; Pei, Z; Tanino, A, 2014) |
| " The aim of our study is to appreciate the clinical usefulness of the dosage serum homocysteine and malondialdehyde, as an oxidative stress marker, in the pregnancies complicated with risk of abortion or preterm birth." | 5.38 | The influence of homocysteine and oxidative stress on pregnancy outcome. ( Antal, L; Bodog, A; Bodog, F; Micle, O; Muresan, M, 2012) |
| " A randomized trial was carried out in 30 young patients with recent acute myocardial infarction (AMI) and high plasma homocysteine concentrations." | 5.11 | Folic acid and vitamin E supplementation effects on homocysteinemia, endothelial function and plasma antioxidant capacity in young myocardial-infarction patients. ( Albertini, F; Archetti, S; Assanelli, D; Bonanome, A; Grassi, M; Maccalli, P; Negrini, R; Pezzini, A; Visioli, F, 2004) |
| "The mechanisms of hyperhomocysteinemia (HHcy) and hyperuricemia (HUA) that promote atherosclerosis were seldom explored and always indefinite." | 4.95 | Role of Hyperhomocysteinemia and Hyperuricemia in Pathogenesis of Atherosclerosis. ( Chen, H; Chen, J; Gu, Y; Liu, N; Yang, K; Zhao, J, 2017) |
| "Hyperhomocysteinemia (HHcy) is known to increase the risk of many diseases." | 4.95 | Determinants of hyperhomocysteinemia in healthy and hypertensive subjects: A population-based study and systematic review. ( Astell-Burt, T; Chen, S; Duan, D; Duan, S; Feng, X; Gu, K; Han, L; Liu, Y; Lu, N; Ma, J; Tang, L; Wang, C; Wang, K; Wen, Q; Xu, G; You, D; Zhang, L; Zhang, T, 2017) |
| "We find evidence that an elevated serum uric acid level is an independent indicator for hyperhomocysteinemia in patients with hypertension." | 4.12 | Serum uric acid concentration is associated with hyperhomocysteinemia in hypertensive Chinese adults. ( Wang, Q; Wang, W; Yang, N, 2022) |
| "Little research has been conducted into the effects of the combined manifestation of hyperuricemia and hyperhomocysteinemia on cardiometabolic risk factors and markers in young subjects." | 4.12 | The Presence of Hyperhomocysteinemia Does Not Aggravate the Cardiometabolic Risk Imposed by Hyperuricemia in Young Individuals: A Retrospective Analysis of a Cross-Sectional Study. ( Gurecká, R; Koborová, I; Podracká, Ľ; Repiská, G; Šebeková, K, 2022) |
| "HHcy: hyperhomocysteinemia; Hcy: homocysteine; VLDL: very low-density lipoprotein; CVD: cardiovascular disease; SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; ALT: alanine aminotransferase; Cr: creatinine; UA: uric acid; TG: triglycerides; TC: total cholesterol; HDL: high-density lipoprotein; LDL: low-density lipoprotein; FBG: fasting blood glucose; CRP: C-reactive protein; MTHFR: methylene tetrahydrofolate reductase; NO: nitric oxide; HDL-C: high-density lipoprotein cholesterol." | 4.02 | Association of serum VLDL level with hyperhomocysteinemia in hypertensive patients: A cross-sectional study. ( Chen, J; Hong, X; Li, J; Wang, J; Wu, M; Zeng, D; Zhang, D; Zhang, Y, 2021) |
| " This study was conducted to investigate the prevalence of hyperhomocysteinemia (HHcy) during routine physical examination in Guangxi Province, China and the correlation of serum Hcy with gender, age, serum uric acid (UA), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and blood glucose (GLU) to provide evidence for preventing and treating HHcy." | 3.88 | Prevalence of hyperhomocysteinemia during routine physical examination in Guangxi Province, China and related risk factors. ( Huang, P; Lai, ZF; Lin, FQ; Qin, JQ; Qin, YY; Wang, P; Wei, AQ, 2018) |
| " Patients with metabolic syndrome (MS) have higher values of homocysteine." | 3.88 | Homocysteine is the confounding factor of metabolic syndrome-confirmed by siMS score. ( Colak, E; Dimitrijevic-Sreckovic, V; Gacic, J; Janeski, H; Janeski, N; Mrdovic, I; Soldatovic, I; Srećković, B; Sumarac-Dumanovic, M, 2018) |
| "Aim To determine the relationship of homocysteine (HCY), uric acid (UA) and C-reactive protein (CRP) in serum of patients with acute myocardial infarction (AMI) prior to application of percutaneous coronary intervention (PCI) and their level of correlation in serum of patients with normal and elevated CRP (predictor of worse cardiovascular outcomes)." | 3.88 | A relation of serum homocysteine, uric acid and C-reactive protein level in patients with acute myocardial infarction. ( Brizić, I; Čaušević, A; Jelić Knezović, N; Marković Boras, M; Mikulić, I; Vasilj, M, 2018) |
| "Patients with both hypertension and hyperhomocysteinemia, termed H-type hypertension, have a high risk for cardiocerebrovascular diseases." | 3.85 | Prevalence of Homocysteine-Related Hypertension in Patients With Chronic Kidney Disease. ( Li, Y; Lou, T; Ma, X; Peng, H; Wang, C; Ye, Z; Zhang, J; Zhang, Q, 2017) |
| "To investigate the related factors of serum uric acid in patients with primary hypertension and hyperhomocysteinemia." | 3.83 | Related factors of serum uric acid in patients with primary hypertension and hyperhomocysteinemia. ( Lin, L; Wang, B; Zhao, C, 2016) |
| "The role of hyperhomocysteinemia in coronary artery disease (CAD) patients remains unclear." | 3.83 | Adenosine plasma level correlates with homocysteine and uric acid concentrations in patients with coronary artery disease. ( Bonatti, S; Bruzzese, L; Cuisset, T; Deharo, P; Fenouillet, E; Fromonot, J; Guieu, R; Mottola, G; Quilici, J; Ruf, J, 2016) |
| "Hyperhomocysteinemia (HHcy) is recognized as a risk factor for cardiovascular disease." | 3.83 | High Prevalence of Hyperhomocysteinemia and Its Association with Target Organ Damage in Chinese Patients with Chronic Kidney Disease. ( Li, Y; Lou, T; Ma, X; Peng, H; Wang, C; Ye, Z; Zhang, J; Zhang, Q, 2016) |
| "Hyperhomocysteinemia and hyperuricemia are both considered risk factors for coronary artery disease." | 3.81 | Assessment of a possible link between hyperhomocysteinemia and hyperuricemia. ( Cohen, E; Garty, M; Goldberg, E; Krause, I; Levi, A; Vecht-Lifshitz, SE, 2015) |
| "Our findings support that hyperhomocysteinemia is a risk factor for AD in an Algerian population and is also associated with vitamin B12 deficiency." | 3.80 | Hyperhomocysteinemia is a risk factor for Alzheimer's disease in an Algerian population. ( Belarbi, S; Bendini, M; Chelouti, H; Djerdjouri, B; El Hadi Cherifi, M; Kacimi, G; Khelil, M; Nazef, K; Tazir, M, 2014) |
| "Hyperhomocysteinemia is one of the important factors of the cardiovascular disease, and gout is well known to be associated with cardiovascular disease." | 3.80 | Elevated serum homocysteine levels were not correlated with serum uric acid levels, but with decreased renal function in gouty patients. ( Choi, ST; Kim, JS; Song, JS, 2014) |
| "In the general adult population, elevated serum homocysteine and uric acid were associated with albuminuria independently of each other and of renal function." | 3.77 | Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study. ( Bochud, M; Marques-Vidal, PM; Marti, F; Mooser, V; Paccaud, F; Vollenweider, P; Waeber, G, 2011) |
| "Information on plasma homocysteine concentrations and their associated factors in Brazilian subjects with metabolic syndrome (MS) is nonexistent." | 3.74 | Association of homocysteinemia with high concentrations of serum insulin and uric acid in Brazilian subjects with metabolic syndrome genotyped for C677T polymorphism in the methylenetetrahydrofolate reductase gene. ( Rosa, G; Uehara, SK, 2008) |
| "Plasma total homocysteine, uric acid and allantoin levels of 50 patients with coronary artery diseases and 23 healthy controls were determined by HPLC methods." | 3.73 | Increased plasma homocysteine and allantoin levels in coronary artery disease: possible link between homocysteine and uric acid oxidation. ( Imren, E; Ozkan, Y; Simşek, B; Torun, M; Yardim-Akaydin, S, 2006) |
| "Hyperhomocysteinemia is a risk factor in obstetrical complications such as pre-eclampsia, 'hemolysis, elevated liver enzymes, low platelet' (HELLP)-syndrome and placental insufficiency." | 3.72 | Alteration of homocysteine catabolism in pre-eclampsia, HELLP syndrome and placental insufficiency. ( Geisel, J; Herrmann, W; Hübner, U; Koch, I; Obeid, R; Retzke, U, 2004) |
| "Patients with combined hyperlipidemia (n = 37) were randomized to receive 9 weeks of treatment with micronized fenofibrate 200 mg/day (F group) or fenofibrate 200 mg/day plus folic acid 10 mg/every other day (F+F group)." | 2.71 | Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine. ( Ceska, R; Grauova, B; Haas, T; Hradec, J; Kozich, V; Krijt, J; Malik, J; Melenovsky, V; Stulc, T; Wichterle, D, 2003) |
| "Hyperhomocysteinemia was defined as a plasma homocysteinemia level >15 μmol/L." | 1.62 | Factors associated with hyperhomocysteinemia in relatively healthy Taiwanese adults: A retrospective medical record study. ( Chen, PJ; Huang, CF; Loke, SS; Lu, YC; Wang, PM, 2021) |
| "In conclusion, hyperhomocysteinemia is associated with carotid RI, a surrogate marker of cerebral vascular resistance, especially in elderly men." | 1.40 | Hyperhomocysteinemia is one of the risk factors associated with cerebrovascular stiffness in hypertensive patients, especially elderly males. ( Enomoto, D; Higaki, J; Irita, J; Kudo, K; Kukida, M; Miyoshi, K; Nagao, T; Okura, T; Pei, Z; Tanino, A, 2014) |
| " The aim of our study is to appreciate the clinical usefulness of the dosage serum homocysteine and malondialdehyde, as an oxidative stress marker, in the pregnancies complicated with risk of abortion or preterm birth." | 1.38 | The influence of homocysteine and oxidative stress on pregnancy outcome. ( Antal, L; Bodog, A; Bodog, F; Micle, O; Muresan, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.13) | 18.2507 |
| 2000's | 7 (21.88) | 29.6817 |
| 2010's | 18 (56.25) | 24.3611 |
| 2020's | 6 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, F | 1 |
| Cui, M | 1 |
| Shi, X | 1 |
| Ju, S | 1 |
| Cong, H | 1 |
| Wang, W | 1 |
| Wang, Q | 1 |
| Yang, N | 1 |
| Niu, XN | 1 |
| Wen, H | 1 |
| Sun, N | 1 |
| Yang, Y | 1 |
| Du, SH | 1 |
| Xie, R | 1 |
| Zhang, YN | 1 |
| Li, Y | 3 |
| Hong, XQ | 1 |
| Šebeková, K | 1 |
| Gurecká, R | 1 |
| Repiská, G | 1 |
| Koborová, I | 1 |
| Podracká, Ľ | 1 |
| Chen, J | 4 |
| Li, J | 1 |
| Wang, J | 1 |
| Zeng, D | 1 |
| Zhang, Y | 1 |
| Wu, M | 1 |
| Zhang, D | 1 |
| Hong, X | 1 |
| Chen, PJ | 1 |
| Lu, YC | 1 |
| Wang, PM | 1 |
| Huang, CF | 1 |
| Loke, SS | 1 |
| Qin, YY | 1 |
| Wang, P | 1 |
| Qin, JQ | 1 |
| Wei, AQ | 1 |
| Huang, P | 1 |
| Lai, ZF | 1 |
| Lin, FQ | 1 |
| Zhao, J | 1 |
| Chen, H | 1 |
| Liu, N | 1 |
| Gu, Y | 1 |
| Yang, K | 1 |
| Srećković, B | 1 |
| Soldatovic, I | 1 |
| Colak, E | 1 |
| Mrdovic, I | 1 |
| Sumarac-Dumanovic, M | 1 |
| Janeski, H | 1 |
| Janeski, N | 1 |
| Gacic, J | 1 |
| Dimitrijevic-Sreckovic, V | 1 |
| Marković Boras, M | 1 |
| Čaušević, A | 1 |
| Brizić, I | 1 |
| Mikulić, I | 1 |
| Vasilj, M | 1 |
| Jelić Knezović, N | 1 |
| Karolczak, K | 1 |
| Soltysik, B | 1 |
| Kostka, T | 1 |
| Witas, PJ | 1 |
| Watala, C | 1 |
| Singh, Y | 1 |
| Samuel, VP | 1 |
| Dahiya, S | 1 |
| Gupta, G | 1 |
| Gillhotra, R | 1 |
| Mishra, A | 1 |
| Singh, M | 1 |
| SreeHarsha, N | 1 |
| Gubbiyappa, SK | 1 |
| Tambuwala, MM | 1 |
| Chellappan, DK | 1 |
| Dua, K | 1 |
| Nazef, K | 1 |
| Khelil, M | 1 |
| Chelouti, H | 1 |
| Kacimi, G | 1 |
| Bendini, M | 1 |
| Tazir, M | 1 |
| Belarbi, S | 1 |
| El Hadi Cherifi, M | 1 |
| Djerdjouri, B | 1 |
| Choi, ST | 1 |
| Kim, JS | 1 |
| Song, JS | 1 |
| Okura, T | 1 |
| Miyoshi, K | 1 |
| Irita, J | 1 |
| Enomoto, D | 1 |
| Nagao, T | 1 |
| Kukida, M | 1 |
| Tanino, A | 1 |
| Kudo, K | 1 |
| Pei, Z | 1 |
| Higaki, J | 1 |
| Cohen, E | 1 |
| Levi, A | 1 |
| Vecht-Lifshitz, SE | 1 |
| Goldberg, E | 1 |
| Garty, M | 1 |
| Krause, I | 1 |
| Fu, Z | 1 |
| Qian, G | 1 |
| Xue, H | 1 |
| Guo, J | 1 |
| Chen, L | 1 |
| Yang, X | 1 |
| Shen, M | 1 |
| Dong, W | 1 |
| Chen, Y | 1 |
| Fromonot, J | 1 |
| Deharo, P | 1 |
| Bruzzese, L | 1 |
| Cuisset, T | 1 |
| Quilici, J | 1 |
| Bonatti, S | 1 |
| Fenouillet, E | 1 |
| Mottola, G | 1 |
| Ruf, J | 1 |
| Guieu, R | 1 |
| Wang, B | 1 |
| Lin, L | 1 |
| Zhao, C | 1 |
| Ye, Z | 2 |
| Wang, C | 3 |
| Zhang, Q | 2 |
| Zhang, J | 2 |
| Ma, X | 2 |
| Peng, H | 2 |
| Lou, T | 2 |
| Han, L | 1 |
| Liu, Y | 1 |
| Tang, L | 1 |
| Feng, X | 1 |
| Astell-Burt, T | 1 |
| Wen, Q | 1 |
| Duan, D | 1 |
| Lu, N | 1 |
| Xu, G | 1 |
| Wang, K | 1 |
| Zhang, L | 1 |
| Gu, K | 1 |
| Chen, S | 1 |
| Ma, J | 1 |
| Zhang, T | 1 |
| You, D | 1 |
| Duan, S | 1 |
| Uehara, SK | 1 |
| Rosa, G | 1 |
| Marti, F | 1 |
| Vollenweider, P | 1 |
| Marques-Vidal, PM | 1 |
| Mooser, V | 1 |
| Waeber, G | 1 |
| Paccaud, F | 1 |
| Bochud, M | 1 |
| Micle, O | 1 |
| Muresan, M | 1 |
| Antal, L | 1 |
| Bodog, F | 1 |
| Bodog, A | 1 |
| Melenovsky, V | 1 |
| Stulc, T | 1 |
| Kozich, V | 1 |
| Grauova, B | 1 |
| Krijt, J | 1 |
| Wichterle, D | 1 |
| Haas, T | 1 |
| Malik, J | 1 |
| Hradec, J | 1 |
| Ceska, R | 1 |
| Assanelli, D | 1 |
| Bonanome, A | 1 |
| Pezzini, A | 1 |
| Albertini, F | 1 |
| Maccalli, P | 2 |
| Grassi, M | 1 |
| Archetti, S | 1 |
| Negrini, R | 2 |
| Visioli, F | 1 |
| Herrmann, W | 1 |
| Hübner, U | 1 |
| Koch, I | 1 |
| Obeid, R | 1 |
| Retzke, U | 1 |
| Geisel, J | 1 |
| Ozkan, Y | 1 |
| Yardim-Akaydin, S | 1 |
| Imren, E | 1 |
| Torun, M | 1 |
| Simşek, B | 1 |
| Rajtar, R | 1 |
| Kloch, M | 1 |
| Bober, M | 1 |
| Kolasińska-Kloch, W | 1 |
| Yoo, JH | 1 |
| Park, JE | 1 |
| Hong, KP | 1 |
| Lee, SH | 1 |
| Kim, DK | 1 |
| Lee, WR | 1 |
| Park, SC | 1 |
| Fernández-Andrade, C | 1 |
5 reviews available for uric acid and Hyperhomocysteinemia
| Article | Year |
|---|---|
Role of Hyperhomocysteinemia and Hyperuricemia in Pathogenesis of Atherosclerosis.
Topics: Animals; Atherosclerosis; Biomarkers; Cell Proliferation; Endoplasmic Reticulum Stress; Endothelium, | 2017 |
Combinational effect of angiotensin receptor blocker and folic acid therapy on uric acid and creatinine level in hyperhomocysteinemia-associated hypertension.
Topics: Angiotensin Receptor Antagonists; Creatinine; Folic Acid; Humans; Hyperhomocysteinemia; Hypertension | 2019 |
Determinants of hyperhomocysteinemia in healthy and hypertensive subjects: A population-based study and systematic review.
Topics: Blood Pressure; Body Mass Index; China; Creatinine; Diet, Healthy; Dietary Supplements; Exercise; Fe | 2017 |
[The current opinion on inflammatory, biochemistry and hemostatic markers and factors in atherosclerosis. Part II].
Topics: Animals; Atherosclerosis; Biomarkers; Causality; Clinical Trials as Topic; Comorbidity; Fibrin Fibri | 2006 |
[Renal markers and predictors, and renal and cardiovascular risk factors].
Topics: Age Factors; Alcohol Drinking; Biomarkers; Blood Pressure; Cardiovascular Diseases; Fatty Acids; Hum | 2002 |
2 trials available for uric acid and Hyperhomocysteinemia
| Article | Year |
|---|---|
Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine.
Topics: Cholesterol; Creatinine; Cysteine; Female; Fenofibrate; Folic Acid; Homocysteine; Humans; Hyperhomoc | 2003 |
Folic acid and vitamin E supplementation effects on homocysteinemia, endothelial function and plasma antioxidant capacity in young myocardial-infarction patients.
Topics: Adult; Antioxidants; Diagnostic Techniques and Procedures; Dietary Supplements; Drug Administration | 2004 |
25 other studies available for uric acid and Hyperhomocysteinemia
| Article | Year |
|---|---|
Distribution characteristics and influencing factors of homocyteine in an apparently healthy examined population.
Topics: Adult; Age Factors; Aged; Biomarkers; Cardiovascular Diseases; China; Cholesterol, HDL; Creatinine; | 2021 |
Serum uric acid concentration is associated with hyperhomocysteinemia in hypertensive Chinese adults.
Topics: Adult; Blood Pressure; China; Cholesterol; Creatinine; Humans; Hyperhomocysteinemia; Hypertension; R | 2022 |
Estradiol and Hyperhomocysteinemia Are Linked Predominantly Through Part Renal Function Indicators.
Topics: Aged; Case-Control Studies; Estradiol; Female; Humans; Hyperhomocysteinemia; Kidney; Middle Aged; Ur | 2022 |
The Presence of Hyperhomocysteinemia Does Not Aggravate the Cardiometabolic Risk Imposed by Hyperuricemia in Young Individuals: A Retrospective Analysis of a Cross-Sectional Study.
Topics: Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Hom | 2022 |
Association of serum VLDL level with hyperhomocysteinemia in hypertensive patients: A cross-sectional study.
Topics: Aged; Alanine Transaminase; Anthropometry; Blood Pressure; Blood Pressure Determination; Body Mass I | 2021 |
Factors associated with hyperhomocysteinemia in relatively healthy Taiwanese adults: A retrospective medical record study.
Topics: Adult; Age Factors; Cross-Sectional Studies; Female; Humans; Hyperhomocysteinemia; Male; Medical Rec | 2021 |
Prevalence of hyperhomocysteinemia during routine physical examination in Guangxi Province, China and related risk factors.
Topics: Adult; Blood Glucose; China; Cross-Sectional Studies; Female; Humans; Hyperhomocysteinemia; Lipids; | 2018 |
Homocysteine is the confounding factor of metabolic syndrome-confirmed by siMS score.
Topics: Adult; Age Factors; Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Confounding Factors, Epidem | 2018 |
A relation of serum homocysteine, uric acid and C-reactive protein level in patients with acute myocardial infarction.
Topics: Aged; Atherosclerosis; Biomarkers; C-Reactive Protein; Female; Homocysteine; Humans; Hyperhomocystei | 2018 |
Platelet and Red Blood Cell Counts, as well as the Concentrations of Uric Acid, but Not Homocysteinaemia or Oxidative Stress, Contribute Mostly to Platelet Reactivity in Older Adults.
Topics: Aged; Erythrocyte Count; Humans; Hyperhomocysteinemia; Multivariate Analysis; Odds Ratio; Oxidative | 2019 |
Hyperhomocysteinemia is a risk factor for Alzheimer's disease in an Algerian population.
Topics: Aged; Aged, 80 and over; Algeria; Alzheimer Disease; Case-Control Studies; Cholesterol; Female; Foli | 2014 |
Elevated serum homocysteine levels were not correlated with serum uric acid levels, but with decreased renal function in gouty patients.
Topics: Glomerular Filtration Rate; Gout; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Ren | 2014 |
Hyperhomocysteinemia is one of the risk factors associated with cerebrovascular stiffness in hypertensive patients, especially elderly males.
Topics: Aged; Blood Pressure; Brain; C-Reactive Protein; Carotid Intima-Media Thickness; Cerebrovascular Dis | 2014 |
Assessment of a possible link between hyperhomocysteinemia and hyperuricemia.
Topics: Adult; Aged; Aged, 80 and over; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hyperuricemia; M | 2015 |
Hyperhomocysteinemia is an independent predictor of long-term clinical outcomes in Chinese octogenarians with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged, 80 and over; Blood Pressure; China; Coronary Angiography; Cystatin C; | 2015 |
Adenosine plasma level correlates with homocysteine and uric acid concentrations in patients with coronary artery disease.
Topics: Adenosine; Aged; Case-Control Studies; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperh | 2016 |
Related factors of serum uric acid in patients with primary hypertension and hyperhomocysteinemia.
Topics: Adult; Aged; Blood Glucose; China; Cholesterol; Creatinine; Cross-Sectional Studies; Essential Hyper | 2016 |
Prevalence of Homocysteine-Related Hypertension in Patients With Chronic Kidney Disease.
Topics: Adolescent; Adult; Aged; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteine | 2017 |
High Prevalence of Hyperhomocysteinemia and Its Association with Target Organ Damage in Chinese Patients with Chronic Kidney Disease.
Topics: Adult; Calcium Phosphates; Carotid Arteries; Carotid Intima-Media Thickness; Cross-Sectional Studies | 2016 |
Association of homocysteinemia with high concentrations of serum insulin and uric acid in Brazilian subjects with metabolic syndrome genotyped for C677T polymorphism in the methylenetetrahydrofolate reductase gene.
Topics: Adult; Body Mass Index; Brazil; Cross-Sectional Studies; Female; Folic Acid Deficiency; Genotype; Ho | 2008 |
Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study.
Topics: Adult; Aged; Albuminuria; Causality; Cross-Sectional Studies; Female; Genotype; Glomerular Filtratio | 2011 |
The influence of homocysteine and oxidative stress on pregnancy outcome.
Topics: Biomarkers; C-Reactive Protein; Ceruloplasmin; Female; Homocysteine; Humans; Hyperhomocysteinemia; M | 2012 |
Alteration of homocysteine catabolism in pre-eclampsia, HELLP syndrome and placental insufficiency.
Topics: Cystathionine; Cystatin C; Cystatins; Female; Folic Acid; HELLP Syndrome; Homocysteine; Humans; Hype | 2004 |
Increased plasma homocysteine and allantoin levels in coronary artery disease: possible link between homocysteine and uric acid oxidation.
Topics: Adult; Aged; Allantoin; Coronary Artery Disease; Female; Homocysteine; Homocystine; Humans; Hyperhom | 2006 |
Moderate hyperhomocyst(e)inemia is associated with the presence of coronary artery disease and the severity of coronary atherosclerosis in Koreans.
Topics: Adult; Aged; Aged, 80 and over; Body Mass Index; Coronary Artery Disease; Coronary Disease; Creatini | 1999 |